177 related articles for article (PubMed ID: 17892915)
1. Restricted field IMRT dramatically enhances IMRT planning for mesothelioma.
Allen AM; Schofield D; Hacker F; Court LE; Czerminska M
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1587-92. PubMed ID: 17892915
[TBL] [Abstract][Full Text] [Related]
2. Combined photon and electron three-dimensional conformal versus intensity-modulated radiotherapy with integrated boost for adjuvant treatment of malignant pleural mesothelioma after pleuropneumonectomy.
Krayenbuehl J; Oertel S; Davis JB; Ciernik IF
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1593-9. PubMed ID: 17931793
[TBL] [Abstract][Full Text] [Related]
3. Effect of increasing experience on dosimetric and clinical outcomes in the management of malignant pleural mesothelioma with intensity-modulated radiation therapy.
Patel PR; Yoo S; Broadwater G; Marks LB; Miles EF; D'Amico TA; Harpole D; Kelsey CR
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):362-8. PubMed ID: 22516382
[TBL] [Abstract][Full Text] [Related]
4. Intensity-modulated radiotherapy for resected mesothelioma: the Duke experience.
Miles EF; Larrier NA; Kelsey CR; Hubbs JL; Ma J; Yoo S; Marks LB
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1143-50. PubMed ID: 18262369
[TBL] [Abstract][Full Text] [Related]
5. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary toxicity following IMRT after extrapleural pneumonectomy for malignant pleural mesothelioma.
Kristensen CA; Nøttrup TJ; Berthelsen AK; Kjaer-Kristoffersen F; Ravn J; Sørensen JB; Engelholm SA
Radiother Oncol; 2009 Jul; 92(1):96-9. PubMed ID: 19364621
[TBL] [Abstract][Full Text] [Related]
7. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma.
Allen AM; Czerminska M; Jänne PA; Sugarbaker DJ; Bueno R; Harris JR; Court L; Baldini EH
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):640-5. PubMed ID: 16751058
[TBL] [Abstract][Full Text] [Related]
8. Dose-dependent pulmonary toxicity after postoperative intensity-modulated radiotherapy for malignant pleural mesothelioma.
Rice DC; Smythe WR; Liao Z; Guerrero T; Chang JY; McAleer MF; Jeter MD; Correa A; Vaporciyan AA; Liu HH; Komaki R; Forster KM; Stevens CW
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):350-7. PubMed ID: 17467922
[TBL] [Abstract][Full Text] [Related]
9. Treatment planning system evaluation for mesothelioma IMRT.
Stevens CW; Wong PF; Rice D; Jeter M; Forster K; Zhu XR
Lung Cancer; 2005 Jul; 49 Suppl 1():S75-81. PubMed ID: 15950806
[TBL] [Abstract][Full Text] [Related]
10. Proton therapy for malignant pleural mesothelioma after extrapleural pleuropneumonectomy.
Krayenbuehl J; Hartmann M; Lomax AJ; Kloeck S; Hug EB; Ciernik IF
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):628-34. PubMed ID: 20385451
[TBL] [Abstract][Full Text] [Related]
11. Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy.
Chera BS; Rodriguez C; Morris CG; Louis D; Yeung D; Li Z; Mendenhall NP
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1173-80. PubMed ID: 19386423
[TBL] [Abstract][Full Text] [Related]
12. Intensity-modulated radiotherapy for neoadjuvant treatment of gastric cancer.
Knab B; Rash C; Farrey K; Jani AB
Med Dosim; 2006; 31(4):292-7. PubMed ID: 17134669
[TBL] [Abstract][Full Text] [Related]
13. Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk.
Fenoglietto P; Laliberte B; Allaw A; Ailleres N; Idri K; Hay MH; Moscardo CL; Gourgou S; Dubois JB; Azria D
Radiother Oncol; 2008 Jul; 88(1):77-87. PubMed ID: 18215434
[TBL] [Abstract][Full Text] [Related]
14. Volumetric modulated arc radiotherapy for carcinomas of the oro-pharynx, hypo-pharynx and larynx: a treatment planning comparison with fixed field IMRT.
Vanetti E; Clivio A; Nicolini G; Fogliata A; Ghosh-Laskar S; Agarwal JP; Upreti RR; Budrukkar A; Murthy V; Deshpande DD; Shrivastava SK; Dinshaw KA; Cozzi L
Radiother Oncol; 2009 Jul; 92(1):111-7. PubMed ID: 19157609
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of larynx-sparing techniques with IMRT when treating the head and neck.
Webster GJ; Rowbottom CG; Ho KF; Slevin NJ; Mackay RI
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):617-22. PubMed ID: 18793966
[TBL] [Abstract][Full Text] [Related]
16. Helical tomotherapy for locoregional irradiation including the internal mammary chain in left-sided breast cancer: dosimetric evaluation.
Caudrelier JM; Morgan SC; Montgomery L; Lacelle M; Nyiri B; Macpherson M
Radiother Oncol; 2009 Jan; 90(1):99-105. PubMed ID: 18977546
[TBL] [Abstract][Full Text] [Related]
17. Compensator-based intensity-modulated radiation therapy for malignant pleural mesothelioma post extrapleural pneumonectomy.
Javedan K; Stevens CW; Forster KM
J Appl Clin Med Phys; 2008 Oct; 9(4):98-109. PubMed ID: 19020484
[TBL] [Abstract][Full Text] [Related]
18. Can intensity-modulated radiation therapy of the paraaortic region overcome the problems of critical organ tolerance?
Hermesse J; Devillers M; Deneufbourg JM; Nickers P
Strahlenther Onkol; 2005 Mar; 181(3):185-90. PubMed ID: 15756523
[TBL] [Abstract][Full Text] [Related]
19. Reducing the low-dose lung radiation for central lung tumors by restricting the IMRT beams and arc arrangement.
Rosca F; Kirk M; Soto D; Sall W; McIntyre J
Med Dosim; 2012; 37(3):280-6. PubMed ID: 22189028
[TBL] [Abstract][Full Text] [Related]
20. The normal tissue sparing obtained with simultaneous treatment of pelvic lymph nodes and bladder using intensity-modulated radiotherapy.
Søndergaard J; Høyer M; Petersen JB; Wright P; Grau C; Muren LP
Acta Oncol; 2009; 48(2):238-44. PubMed ID: 18759144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
